Neurology Articles

Neurology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Haycox A et al. – Rasagiline was the dominant strategy. Compared with pramipexole, use of the rasagiline strategy was estimated to reduce costs by 18% per patient over 5 years and was associated with an additional 10% delay in dyskinesia onset. This strategy was also found to prolong the time to levodopa initiation by 25% through a gain of 0.83 levodopa–free years. In addition, use of the rasagiline strategy was found to generate a 5% gain in QALYs over 5 years compared with the pramipexole strategy. Sensitivity analyses confirmed that the model was robust. Rasagiline represents a cost–effective alternative to pramipexole in the treatment of early PD in the UK.

Related Articles

Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
Brain, 10/30/09    Relevance Score: 70%

Widely Used Cholesterol-lowering Drug May Prevent Progression Of Parkinsons Disease
ScienceDaily, 11/10/09    Relevance Score: 69%

Condition Raises Parkinsons Risk 5-Fold
Ivanhoe, 10/27/09    Relevance Score: 69%

Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease
Parkinsonism & Related Disorders, 10/29/09    Relevance Score: 68%

Sleep disturbances in Malaysian patients with Parkinson's disease using polysomnography and PDSS
Parkinsonism & Related Disorders, 10/29/09    Relevance Score: 68%

Today in Movement Disorders...keeping you current

Stimulation-Induced Dyskinesia in the Early Stage after Subthalamic Deep Brain Stimulation
Stereotactic and Functional Neurosurgery , 11/25/09

Proton Pump Inhibitors and Pain
Pain Physician, 11/25/09

Pediatric Constraint-Induced Movement Therapy: A Promising Intervention for Childhood Hemiparesis
Topics in Stroke Rehabilitation, 11/24/09

Today in Neuro/Psych pharmacology...keeping you current

Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine2A Inverse Agonist for the Treatment of Insomnia
Journal of Pharmacology and Experimental Therapeutics, 11/25/09

Effect of cilnidipine vs losartan on cerebral blood flow in hypertensive patients with a history of ischemic stroke: a randomized controlled trial
Acta Neurologica Scandinavica, 11/25/09

Association of higher carbohydrate intake with depressive mood in elderly diabetic women
Nutritional Neuroscience, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address